1 / 6

Pomahope 3mg Capsule | Apple pharmaceuticals

Pomahope 3mg capsule (Pomalidomide) is therapeutically categorized as an anti-neoplastic agent, which is active in multiple myeloma condition, these capsules are used by the patients who are having a prescription specify by practiced medical oncologist.

RobbieRoyce
Télécharger la présentation

Pomahope 3mg Capsule | Apple pharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. APPLEPHARMACEUTICALS We will not dispense any prescription medication without a valid prescription from a licensed physician.

  2. POMALIDOMIDE Pomahope3mg

  3. DESCRIPTION • INDICATION • The therapeutic indication of Pomahope3mg is involved in condition like Multiple myeloma. In this condition, Pomahope3mg is utilized by consolidating with dexamethasone. • Pomahope3mg cases are relevant in; • Patients formerly regarded with two treatments, for example, proteasome inhibitor and Lenalidomide. Pomahope3mg is therapeutically categorized as an anti-neoplastic agent, which is active in multiple myeloma condition. Pomahope3mg capsules are used by the patients who are having a prescription specify by practiced medical oncologist.

  4. MECHANISM • DOSAGE Pomalidomide has three noteworthy pharmacological exercises against tumor cells. Pomalidomide includes in impeding the malignancy duplication and creates the apoptosis of disease cells. Pomalidomide increase the T cell and natural killer cells interceding insusceptibility and forbid the development of professional provocative cytokines from monocytes. • The most common indication of Pomahope is involved in the treatment of Multiple Myeloma condition. The usual advised dose of Pomahope is 4mg tablet should be administered orally as once a day for cycles of 1 to 21 days for ensuing 28-day cycles. During this treatment, Pomahope should be combinely used with low dose of dexamethasone. Dexamethasone should be administered on day 1, 8, 15 & 22 of every 28 days cycles.

  5. PREGNANCY LACTATION • Breast feeding should not be recommended. Pregnancy category of Pomahope3mg is categorized as X, X means causes fetal damage during the Pomahope3mg treatment. Pomahope3mg causes embryo fetal damage. • STORAGE • Pomahope3mg capsules container should be keep in a temperature of 20°C to 25°C. • Do not store the container in light • Protect from moisture & heat.

  6. CALL CONTACT US • +91-9987711567 MAIL VISIT US • applepharmaceutical@gmail.com • http://anti-cancer-drugs.com/ ADDRESS Apartment No.304 A Wing, Shiva Shakthichs ltd, JP Road, Near Apna Bazar,Andheri(West),Mumbai - 400058.

More Related